학술논문
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.
Document Type
Journal Article
Author
Source
Subject
*ANTINEOPLASTIC agents
*CANCER relapse
*IMMUNOGLOBULINS
*LONGITUDINAL method
*MULTIPLE myeloma
*PROGNOSIS
*RESEARCH funding
*SURVIVAL
*TUMOR classification
*DISEASE remission
*RETROSPECTIVE studies
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0887-6924
Abstract
Normalization of the serum-free light-chain ratio (FLCr) with the absence of bone marrow monoclonal plasma cells following achievement of a complete response (CR) to therapy denotes a stringent CR in multiple myeloma (MM), and is associated with improved overall survival (OS). However, its value in patients achieving